Skip to main content
Signal8

ENHANCED PROVIDES CLINICAL TRIAL UPDATE - FIRST OF ITS KIND STUDY CONTINUES WITH ATHLETES HEALTHY & SAFE TO COMPETE

$ENHAPress releaseMay 20, 2026, 5:53 PM ETRead the release

Enhanced Group announced that the interventional phase of its ASCEND001 clinical trial has concluded, with the five-year observational monitoring period now commencing. The study, posted to ClinicalTrials.gov, covered 36 of the 42 athletes competing in the upcoming Enhanced Games, confirming they are healthy and safe to compete. Aggregate data revealed high usage of performance-enhancing substances among participants, including 91% using testosterone and 79% using human growth hormone, all under medical supervision.

Key figures

Epo usage pct
41%
Hgh usage pct
79%
Athletes in trial
36
Stimulant usage pct
62%
Testosterone usage pct
91%
Total athletes competing
42
Anabolic steroid usage pct
29%
Hormonal support usage pct
5%
Metabolic modulator usage pct
50%

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.